118 related articles for article (PubMed ID: 22198442)
1. All-cause mortality and medication risk factors in schizophrenia: a prospective cohort study.
Tenback D; Pijl B; Smeets H; Os Jv; Harten Pv
J Clin Psychopharmacol; 2012 Feb; 32(1):31-5. PubMed ID: 22198442
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study.
Baandrup L; Gasse C; Jensen VD; Glenthoj BY; Nordentoft M; Lublin H; Fink-Jensen A; Lindhardt A; Mortensen PB
J Clin Psychiatry; 2010 Feb; 71(2):103-8. PubMed ID: 19895781
[TBL] [Abstract][Full Text] [Related]
3. Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia.
Broder MS; Bates JA; Jing Y; Hebden T; Forbes RA; Chang E
J Med Econ; 2012; 15(1):105-11. PubMed ID: 21991926
[TBL] [Abstract][Full Text] [Related]
4. Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study.
Ward A; Ishak K; Proskorovsky I; Caro J
Clin Ther; 2006 Nov; 28(11):1912-21. PubMed ID: 17213012
[TBL] [Abstract][Full Text] [Related]
5. Mortality and its determinants in people with psychotic disorder.
Suvisaari J; Partti K; Perälä J; Viertiö S; Saarni SE; Lönnqvist J; Saarni SI; Härkänen T
Psychosom Med; 2013 Jan; 75(1):60-7. PubMed ID: 23257931
[TBL] [Abstract][Full Text] [Related]
6. Serious cardiovascular events and mortality among patients with schizophrenia.
Enger C; Weatherby L; Reynolds RF; Glasser DB; Walker AM
J Nerv Ment Dis; 2004 Jan; 192(1):19-27. PubMed ID: 14718772
[TBL] [Abstract][Full Text] [Related]
7. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).
Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Niskanen L; Tanskanen A; Haukka J
Lancet; 2009 Aug; 374(9690):620-7. PubMed ID: 19595447
[TBL] [Abstract][Full Text] [Related]
8. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
10. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.
Mehta S; Johnson ML; Chen H; Aparasu RR
J Clin Psychiatry; 2010 Jun; 71(6):689-98. PubMed ID: 20573328
[TBL] [Abstract][Full Text] [Related]
11. Somnolence effects of antipsychotic medications and the risk of unintentional injury.
Said Q; Gutterman EM; Kim MS; Firth SD; Whitehead R; Brixner D
Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):354-64. PubMed ID: 18314925
[TBL] [Abstract][Full Text] [Related]
12. Medication discontinuation with depot and oral antipsychotics in outpatients with schizophrenia: comparison of matched cohorts from a 12-month observational study.
Brnabic AJ; Kelin K; Ascher-Svanum H; Montgomery W; Kadziola Z; Karagianis J
Int J Clin Pract; 2011 Sep; 65(9):945-53. PubMed ID: 21849009
[TBL] [Abstract][Full Text] [Related]
13. Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
Wang PS; Schneeweiss S; Avorn J; Fischer MA; Mogun H; Solomon DH; Brookhart MA
N Engl J Med; 2005 Dec; 353(22):2335-41. PubMed ID: 16319382
[TBL] [Abstract][Full Text] [Related]
14. [Mortality among chronic schizophrenic patients: a prospective 14-year follow-up study of 150 schizophrenic patients].
Loas G; Azi A; Noisette C; Yon V
Encephale; 2008 Jan; 34(1):54-60. PubMed ID: 18514151
[TBL] [Abstract][Full Text] [Related]
15. Adverse events in elderly users of antipsychotic pharmacotherapy in the province of Manitoba: a retrospective cohort study.
Vasilyeva I; Biscontri RG; Enns MW; Metge CJ; Alessi-Severini S
J Clin Psychopharmacol; 2013 Feb; 33(1):24-30. PubMed ID: 23277238
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Adjunctive Psychotropic Medications in Patients With Schizophrenia.
Stroup TS; Gerhard T; Crystal S; Huang C; Tan Z; Wall MM; Mathai C; Olfson M
JAMA Psychiatry; 2019 May; 76(5):508-515. PubMed ID: 30785609
[TBL] [Abstract][Full Text] [Related]
18. Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications.
Setoguchi S; Wang PS; Alan Brookhart M; Canning CF; Kaci L; Schneeweiss S
J Am Geriatr Soc; 2008 Sep; 56(9):1644-50. PubMed ID: 18691283
[TBL] [Abstract][Full Text] [Related]
19. Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP).
Thomas SH; Drici MD; Hall GC; Crocq MA; Everitt B; Lader MH; Le Jeunne C; Naber D; Priori S; Sturkenboom M; Thibaut F; Peuskens J; Mittoux A; Tanghøj P; Toumi M; Moore ND; Mann RD
Acta Psychiatr Scand; 2010 Nov; 122(5):345-55. PubMed ID: 20384598
[TBL] [Abstract][Full Text] [Related]
20. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
